Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Clinical practice
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    As Oncology Nurses, We Are the Fish
    Oncology nurse pride
    As Oncology Nurses, We Are the Fish
    May 20, 2022
    Patients and the Public Recognize and Thank Dedicated Nurses
    Nurse empowerment
    Patients and the Public Recognize and Thank Dedicated Nurses
    May 06, 2022
    How to Promote and Maintain Cancer Screening as COVID-19 Persists
    Cancer screening
    How to Promote and Maintain Cancer Screening as COVID-19 Persists
    March 18, 2022
    I’m a Match: My Journey From Advanced Practice BMT Nurse to Stem Cell Transplant Donor
    Oncology nurse pride
    I’m a Match: My Journey From Advanced Practice BMT Nurse to Stem Cell Transplant Donor
    February 11, 2022
    Online and Mobile Resources Prepare Oncology Professionals for Care Delivery in All Settings
    Oncology nurse pride
    Online and Mobile Resources Prepare Oncology Professionals for Care Delivery in All Settings
    January 31, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Research

    Use the Evidence to Integrate Ethics  in Teleoncology Care
    Oncology nurse-patient relationship

    Use the Evidence to Integrate Ethics in Teleoncology Care

    Emily manages a rural clinic associated with an academic cancer center. Patients initially have an in-person consultation with their treating oncologists at the main campus but then use telehealth for subsequent visits. To support patients during teleoncology visits, Emily wants to initiate a plan to collaborate with the clinic staff to identify and address the ethical principles for oncology care using telehealth.

    May 17, 2022
    AI Ultrasound Is Nearly 100% Accurate in Detecting Thyroid Cancers
    Cancer research

    AI Ultrasound Is Nearly 100% Accurate in Detecting Thyroid Cancers

    Ultrasound imaging guided with artificial intelligence (AI) noninvasively detects almost all malignant thyroid nodules, researchers reported at the 2022 Multidisciplinary Head and Neck Cancers Symposium. It is also accurate when predicting T stage, extracapsular extension, and presence of a BRAF variant.

    May 11, 2022
    Oncology Navigation Standards Help Patients Overcome Disparities and Barriers to Care
    Cancer health disparities

    Oncology Navigation Standards Help Patients Overcome Disparities and Barriers to Care

    Patients with cancer, especially those from underrepresented groups or who are experiencing racism, inequalities, social determinants of health factors, and other barriers to care, need oncology nurse navigation now more than ever before. Developed as a “strategy to improve outcomes in marginalized populations by eliminating barriers to timely diagnosis and treatment of cancer and other chronic diseases,” navigation has made a difference for patients since its introduction in 1990.

    May 10, 2022
    U.S. Representative Pallone Questions Vaping Companies on Teen Marketing
    Cancer risk prevention

    U.S. Representative Pallone Questions Vaping Companies on Teen Marketing

    As the U.S. Food and Drug Administration (FDA) continues its review of tobacco and e-cigarette products’ marketing applications, legislators and government officials, such as Energy and Commerce Committee Chair Frank Pallone, Jr. (D-NJ), are taking a stand and sharing their concerns on Big Tobacco’s marketing to teenage audiences.

    May 05, 2022
    More Patients Are Skipping Their Cervical Cancer Screenings
    Research

    More Patients Are Skipping Their Cervical Cancer Screenings

    Nearly a quarter of patients who are eligible for cervical cancer screening are overdue for their current tests, researchers said in study findings published in JAMA Network Open. The number grew nearly 10% since 2005—representing a steady increase in missed screening over time—and was higher in different sociodemographic groups because of factors related to social determinants of health.

    May 04, 2022
    CAR T-Cell Therapy Programs
    Cancer treatments

    CAR T-Cell Therapy Programs

    Debuting in human clinical trials just a decade ago, chimeric antigen receptor (CAR) T-cell therapy was quickly hailed as a breakthrough cancer treatment for certain hematologic cancers. Today, patients and providers have access to 22 U.S. Food and Drug Administration (FDA)–approved cellular and gene therapy products, and CAR T-cell therapy is available beyond large academic research centers.

    May 03, 2022
    Robert Otto Valdez Appointed AHRQ Director
    Research

    Robert Otto Valdez Appointed AHRQ Director

    Internationally recognized for expertise in health services research, the U.S. healthcare system, and health policy analysis, Robert Otto Valdez, PhD, MHSA, was appointed as director of the Agency for Healthcare Research and Quality (AHRQ) in February 2022, where he leads the agency’s work in improving and promoting patient safety.

    April 20, 2022
    Younger Nurses Are Leaving the Profession Because of Emotional Health
    Nurse well-being

    Younger Nurses Are Leaving the Profession Because of Emotional Health

    Young nurses are “less emotionally healthy and less optimistic about the future,” even after accounting for age and years of nursing experience, according to findings from a 2022 study conducted by the American Nurses Foundation. High levels of burnout correlate with drones of professionals leaving the nursing field, the foundation said in its Pulse on the Nation’s Nurses Survey Series: COVID-19 Two-Year Impact Assessment Survey.

    April 07, 2022
    What the Evidence Says About Low-Intensity Exercise in Cancer Care
    Complementary therapy

    What the Evidence Says About Low-Intensity Exercise in Cancer Care

    Regular, light-intensity exercise and activity has been shown to reduce the risks of fractures, heart disease, and death. Substantial evidence also indicated benefits for cancer-related outcomes, including fatigue, depression, and quality of life. Additional observational data suggested that sustained physical activity may help reduce cancer recurrence and improve overall survival.

    March 30, 2022
    Nursing Diversity Is Critical to Address Health Disparities
    Oncology nurse influence

    Nursing Diversity Is Critical to Address Health Disparities

    Following the death of George Floyd in May 2020, I found myself surrounded by oncology nurses who recognized the need for immediate action to understand and deconstruct racism, and I began collecting resources to offer continuing education about the effects of racism on cancer outcomes and actions nurses can take to support health equity and diversity in the workforce. Under the mentorship of ONS Past President Mary Gullatte, PhD, RN, ANP-BC, AOCN®, FAAN, I was charged by ONS to co-lead, with ONS member Randy Jones, PhD, RN, FAAN, a national team of ONS cancer disparities and health equity researchers to update the ONS Research Agenda.

    March 08, 2022
    E-Cigarettes Affect Adults and Kids Differently, FDA Center for Tobacco Products Director Says
    Patient safety

    E-Cigarettes Affect Adults and Kids Differently, FDA Center for Tobacco Products Director Says

    Balancing the benefits of e-cigarettes for adults with the harms makes regulating e-cigarette marketing particularly challenging, U.S. Food and Drug Administration (FDA) Center for Tobacco Products Director Mitch Zeller, JD, said in a January 2022 interview with the National Cancer Institute (NCI). FDA continuously evaluates e-cigarettes and tobacco companies’ marketing strategies, and Zeller says it’s up to tobacco companies to make those differences clear in their advertising.

    February 23, 2022
    New HHS Initiative Will Reduce Maternal and Infant Health Disparities
    Cancer health disparities

    New HHS Initiative Will Reduce Maternal and Infant Health Disparities

    To reduce the disparities affecting maternity health outcomes, the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) launched the Maternal Morbidity and Mortality Data and Analysis Initiative, an $8 million contract with Premier, Inc., the agency announced in December 2021. The initiative is rallying a network of hospitals to deploy evidence-based best practices in maternity care.

    January 14, 2022
    Families See Increase in Healthcare Premiums, Increase in Covered Services
    Patient resources

    Families See Increase in Healthcare Premiums, Increase in Covered Services

    Employer-sponsored health insurance premiums increased by 4% for families in 2021, bringing the average annual cost to $22,221 per family, according to the results of a benchmark Kaiser Family Foundation (KFF) Employer Health Benefits survey released in November 2021. KFF also assessed the COVID-19 pandemic’s impact on workplace health benefits, including telemedicine and mental health services.

    January 13, 2022
    Local Policies Have Reduced Availability, Use of Flavored Tobacco Products
    Research

    Local Policies Have Reduced Availability, Use of Flavored Tobacco Products

    Local policies have reduced the availability and youth and adult use of products like flavored e-cigarettes and menthol cigarettes compared to areas without restrictions, the Truth Initiative reported after the first comprehensive quality review that looked at the outcomes of flavor and menthol tobacco restrictions. The research, which was conducted in partnership with the Research Triangle Institute, was published in Nicotine and Tobacco Research.

    January 12, 2022
    Black Patients at Higher Risk for Infection, Poor Outcomes From COVID-19 During Cancer
    COVID-19

    Black Patients at Higher Risk for Infection, Poor Outcomes From COVID-19 During Cancer

    Patients with cancer are more likely to contract the COVID-19 coronavirus and experience complications from the infection—and the risk is highest for Black patients, study findings show. Researchers published the report in JAMA Oncology.

    December 15, 2021
    Racism, Health Inequities, and Unequal Access to Care Are Oncology Nursing Research Priorities
    Access to cancer care

    Racism, Health Inequities, and Unequal Access to Care Are Oncology Nursing Research Priorities

    Racial inequality persists across the entire healthcare spectrum—from patient disparities to the healthcare workforce’s current makeup and even to the education of the next generation of practitioners. But nurse scientists conducting clinical trials have the opportunity to change that.

    December 14, 2021
    Patients Cope With Intense Emotions After Clinical Trial Withdrawal
    Oncology clinical trials

    Patients Cope With Intense Emotions After Clinical Trial Withdrawal

    When withdrawing from a clinical trial, patients experience a spectrum of emotions ranging from regret, urgency, frustration—and trust in their healthcare professionals, like oncology nurses, according to the results of a study published in JAMA Network Open.

    December 08, 2021
    Biden Brings Robert Califf Back to FDA
    U.S. Food and Drug Administration (FDA)

    Biden Brings Robert Califf Back to FDA

    Citing his extensive medical background and leadership experience, in November 2021, President Joe Biden nominated Robert Califf, MD, MACC, adjunct professor of medicine, professor of cardiology, and member of the Duke Clinical Research Institute at the Duke University School of Medicine in Durham, NC, as U.S. Food and Drug Administration (FDA) commissioner. Califf will assume the role once confirmed by the U.S. Senate.

    November 30, 2021
    FDA Approves Sirolimus Protein-Bound Particles for Malignant Perivascular Epithelioid Cell Tumor
    U.S. Food and Drug Administration (FDA)

    FDA Approves Sirolimus Protein-Bound Particles for Malignant Perivascular Epithelioid Cell Tumor

    On November 22, 2021, the U.S. Food and Drug Administration (FDA) approved sirolimus protein-bound particles for injectable suspension (Fyarro™) for adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).

    November 23, 2021
    Genetic Disorder Reference Sheet: Familial Adenomatous Polyposis
    Genetics & genomics

    Genetic Disorder Reference Sheet: Familial Adenomatous Polyposis

    Individuals with 10–100+ polyps may have a germline pathogenic variant in the APC gene, placing them at higher risk for developing colorectal, gastrointestinal, and other cancers. The condition is known as familial adenosis polyposis (FAP), and loss of function in the APC gene is the first step in the adenoma-to-carcinoma sequence. Some people have an attenuated form (aFAP), with delayed polyp growth and fewer polyps (see sidebar). As many as 20% are de novo, meaning that they are the first in their family to have an identified pathogenic variant.

    November 04, 2021
    Bringing Biosignatures to the Bedside
    Targeted therapy

    Bringing Biosignatures to the Bedside

    With the growth of genomics and targeted therapy, nurse scientists are gaining deeper understanding the vast facets of patients’ symptom experience, and biosignatures could be the key to unlocking the next frontier in symptom science research.

    November 02, 2021
    Combination Immunotherapy May Further Increase Melanoma Survival Length
    Melanoma

    Combination Immunotherapy May Further Increase Melanoma Survival Length

    Using two agents that target two different receptors more than doubles length of survival for advanced melanoma than a single agent alone, researchers reported at the 2021 American Society of Clinical Oncology annual meeting.

    October 27, 2021
    New Study Supports CRC Screening for People Older Than 75
    Cancer screening

    New Study Supports CRC Screening for People Older Than 75

    Colorectal cancer (CRC) screening may be beneficial for certain patients aged 75–85, according to findings from a new study. The researchers reported the results in JAMA Oncology.

    October 20, 2021
    Genetic Disorder Reference Sheet: ATM Pathogenic Variants
    Genetics & genomics

    Genetic Disorder Reference Sheet: ATM Pathogenic Variants

    An estimated 1%–2% of adults have one pathogenic ataxia telangiectasia mutated (ATM) gene variant (heterozygous) and are considered carriers. People who are homozygous (two altered copies) have ataxia-telangiectasia (A-T), a hereditary condition that often appears in childhood and is characterized by progressive neurologic problems that lead to difficulty walking and an increased risk for developing various malignancies. Children with A-T may begin staggering and appear unsteady (ataxia) shortly after learning to walk.

    October 18, 2021
    FDA Reports Worldwide Recall of Lidocaine HCl Topical Solution 4% Because of Super Potency
    U.S. Food and Drug Administration (FDA)

    FDA Reports Worldwide Recall of Lidocaine HCl Topical Solution 4% Because of Super Potency

    On October 13, 2021, the U.S. Food and Drug Administration (FDA) reported Teligent Pharma’s voluntary recall of five lots of lidocaine HCl topical solution 4% in a 50 ml screw cap glass bottle to the user level because the firm’s testing found it to be super potent based on an out-of-specification result obtained at the 18-month stability timepoint.

    October 14, 2021
    HER2 Therapies May Be Effective in a Variety of Solid Tumors
    Research

    HER2 Therapies May Be Effective in a Variety of Solid Tumors

    Researchers have found that 2%–3% of all solid tumors overexpress or amplify HER2 protein that may be a target for drugs such as pertuzumab and trastuzumab, particularly in KRAS-variant disease. They presented their findings during the 2021 American Society of Clinical Oncology annual meeting.

    October 13, 2021
    Pilot Study Shows Positive Impact of ONS Get Up, Get Moving Campaign
    Press Releases

    Pilot Study Shows Positive Impact of ONS Get Up, Get Moving Campaign

    PITTSBURGH, PA—October 12, 2021—Research shows that physical activity during cancer treatment mitigates some of the negative physical and psychosocial outcomes associated with diagnosis and treatment. Released in the October 2021 issue of the Clinical Journal of Oncology Nursing, results of a pilot study by Judi K. Forner, DNP, APRN, ACNS-BC, RN-BC, Andrea Doughty, PhD, Matthew David Dalstrom, PhD, MPH, Brandie L. Messer, DNP, RN, PCOE, and Shannon K. Lizer, PhD, APRN, FNP-BC, FAANP, demonstrated the positive impact of the Oncology Nursing Society’s (ONS’s) Get Up, Get Moving program.

    October 12, 2021
    It Takes a Team to Confront Moral Distress
    Compassion fatigue

    It Takes a Team to Confront Moral Distress

    Unbearable levels of stress, burnout, frustration, disappointment, and even fear are plaguing today’s healthcare providers more than ever before. But for oncology nurses, moral distress and compassion fatigue have always been in the background when caring for patients with a serious illness.

    October 12, 2021
    PhD and DNP Students Collaborate to Implement Practice-Driven Research
    Nursing evidence-based practice

    PhD and DNP Students Collaborate to Implement Practice-Driven Research

    Evidence-based practice is dual sided: nurse scientists conduct research, and clinical nurses implement those findings into practice. Working together, they improve care by developing cancer survivorship programs, reducing cancer risk, and assessing cancer care in vulnerable populations. The University of Washington School of Nursing’s (UW SoN’s) partnership with Confluence Health, one of the largest healthcare providers in north central Washington, built a novel program to identify gaps in research and implementation and elicit projects that influence healthcare outcomes.

    October 05, 2021
    FDA Issues Marketing Denial Orders for 55,000 Flavored E-Cigarette Products
    U.S. Food and Drug Administration (FDA)

    FDA Issues Marketing Denial Orders for 55,000 Flavored E-Cigarette Products

    In August 2021, the U.S. Food and Drug Administration (FDA) denied about 55,000 flavored e-cigarette products’ marketing applications for failing to provide evidence that they appropriately protect public health.

    October 01, 2021
    Proton Pump Inhibitors May Boost Radiation’s Effects
    Radiation therapy

    Proton Pump Inhibitors May Boost Radiation’s Effects

    September 29, 2021
    FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations
    U.S. Food and Drug Administration (FDA)

    FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations

    On September 22, 2021, the U.S. Food and Drug Administration (FDA) granted emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine for use as a single booster dose administered at least six months after completion of the primary series in individuals aged 65 and older, individuals aged 18–64 at high risk for severe COVID-19, and individuals aged 18–64 whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk for serious complications of COVID-19 or severe COVID-19.

    September 27, 2021
    What the Evidence Says for Traditional Chinese Medicine Ma Zi Ren Wan for Constipation
    Complementary therapy

    What the Evidence Says for Traditional Chinese Medicine Ma Zi Ren Wan for Constipation

    A common and distressing symptom among patients with a variety of health diagnoses as well as the general population, constipation is characterized by reduced stool frequency, incomplete evacuation, straining, and a sense of anorectal blockage. Nearly 43%–58% of patients with cancer report constipation caused by a variety of factors, including organic, functional, or drug associated. Standard treatment options such as fiber supplements, laxatives, and stool softeners are not entirely effective and can cause adverse effects.

    September 24, 2021
    Antibiotics May Reduce Checkpoint Inhibitor Efficacy
    Research

    Antibiotics May Reduce Checkpoint Inhibitor Efficacy

    Using antibiotics during treatment with immune checkpoint inhibitors may limit the therapy’s effect, according to study results published in the American Journal of Clinical Oncology.

    September 22, 2021
    FDA Reprimands Tobacco Company for Not Meeting Premarketing Filing Requirements
    U.S. Food and Drug Administration (FDA)

    FDA Reprimands Tobacco Company for Not Meeting Premarketing Filing Requirements

    On August 9, 2021, the U.S. Food and Drug Administration issued a refuse-to-file letter (RTF) to JD Nova Group, notifying the company that their premarket tobacco product applications associated with approximately 4.5 million of their products do not meet the filing requirements for a new tobacco product seeking a marketing order.

    September 16, 2021
    ONS Bridge

    How One Organization Developed Tools to Predict Opioid Use Disorder Among Patients

    Opioids are one strategy to help manage the cancer-related pain that nearly 75% of patients with cancer experience throughout the disease or its treatment. However, the prevalence of opioid misuse disorder (OUD) among patients with cancer is believed to be at least equal to that of the general population, Debra Rodrigue, MA, RN-BC, AOCNS®, explained during a session for the ONS BridgeTM virtual conference on September 9, 2021.

    September 09, 2021
    Prognostic Biomarkers May Help Predict Rhabdomyosarcoma Outcomes
    Research

    Prognostic Biomarkers May Help Predict Rhabdomyosarcoma Outcomes

    TP53 and MYOD1 variants are associated with more aggressive forms of rhabdomyosarcoma, a rare childhood cancer, and poorer outcomes, according to the results of the largest international genomic profiling study of the disease. The findings, which were published in the Journal of Clinical Oncology, have implications for somatic biomarker testing to guide tailored treatment approaches.

    September 09, 2021
    BTK Inhibitor Effective for Relapsed Hairy Cell Leukemia
    Research

    BTK Inhibitor Effective for Relapsed Hairy Cell Leukemia

    Ibrutinib produces durable disease control for patients with high-risk hairy cell leukemia, a rare cancer, who have relapsed and for whom standard purine analogues are not a feasible therapeutic option, according to study results published in Blood.

    September 08, 2021
    FDA Grants Full Approval for First COVID-19 Vaccine
    U.S. Food and Drug Administration (FDA)

    FDA Grants Full Approval for First COVID-19 Vaccine

    On August 23, 2021, the U.S. Food and Drug Administration (FDA) approved the Pfizer-BioNTech COVID-19 vaccine, now marketed as Comirnaty, for the prevention of COVID-19 coronavirus infection in individuals aged 16 years and older. The vaccine is still under emergency use authorization (EUA) for individuals aged 12–15 years and as a third dose in certain immunocompromised individuals.

    August 25, 2021
    Researchers Study Innate Immunity Throughout History to Determine New Methods of Cancer Treatment
    Research

    Researchers Study Innate Immunity Throughout History to Determine New Methods of Cancer Treatment

    Evolution may be the key to understanding immunity—or at least the National Institutes of Health (NIH) thinks so. Studies of the history of human life could uncover discoveries that have implications for all types of disease, including cancer.

    August 18, 2021
    FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Advanced Solid Tumors
    U.S. Food and Drug Administration (FDA)

    FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Advanced Solid Tumors

    On August 17, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to dostarlimab-gxly (Jemperli®) for adult patients with mismatch repair deficient (dMMR) recurrent or advanced solid tumors, as determined by an FDA-approved test, that have progressed on or following prior treatment and who have no satisfactory alternative treatment options.

    August 18, 2021
    Whole-Genome Sequencing May Guide Treatment Choices for AML and MDS
    Genetics & genomics

    Whole-Genome Sequencing May Guide Treatment Choices for AML and MDS

    When compared to conventional testing on the same samples from patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS), whole-genome sequencing–based testing detected the same abnormalities—and new genetic information in about a quarter of patients, potentially changing treatment selection for more than half of those patients, researchers said in the New England Journal of Medicine.

    August 18, 2021
    Overall Youth Tobacco Use Declines, but E-Cigarette Use Climbs, According to National Survey Results
    Lung Cancer

    Overall Youth Tobacco Use Declines, but E-Cigarette Use Climbs, According to National Survey Results

    American youth reported a decline in using any tobacco product in 2020 compared to 2019 but no significant decrease in the use of cigarettes, hookah, pipe tobacco, or heated tobacco products, according to 2020 U.S. Food and Drug Administration (FDA) survey findings on youth tobacco use. Despite the decline, FDA said that the data shows “disturbingly high rates of frequent and daily e-cigarette use” and strong nicotine dependence among youth.

    August 16, 2021
    Researchers Tie More Cancers, Mortality to NF1 Disorders
    Cancer research

    Researchers Tie More Cancers, Mortality to NF1 Disorders

    The genetic disorder neurofibromatosis type 1 (NF1) is linked to the development of and mortality for more types of cancer than previously identified, researchers reported in results from a new study. They published the findings in JAMA Network Open.

    August 11, 2021
    Biden-Harris Administration’s FY 2022 Discretionary Funding Request Includes Proposals to Advance Public Health
    Health Policy

    Biden-Harris Administration’s FY 2022 Discretionary Funding Request Includes Proposals to Advance Public Health

    In its first year, new presidential administrations release a skinny budget that contains more topline items rather than deep dives into each agency and subdivision. Following suit, in April 2021 the Biden-Harris administration released its request for discretionary funding with limited definition, but it was enough to foreshadow the fiscal year (FY) 2022 funding cycle.

    August 06, 2021
    Heart Failure May Increase Risk for Certain Cancers
    Research

    Heart Failure May Increase Risk for Certain Cancers

    Patients with heart failure have a 75% increased risk of developing cancer, researchers reported in ESC Heart Failure. And cancer incidence rates were even higher for specific disease sites.

    August 04, 2021
    The Seven Dimensions of Rest
    Nurse well-being

    The Seven Dimensions of Rest

    Sleep and rest are two different concepts. Society focuses on sleep, but rest is just as important, and not just for the physical body. Rest allows us to nurture our physical, mental, emotional, sensory, creative, social, and spiritual self. Each of those dimensions needs to be consciously rested for a person to truly feel restored.

    July 29, 2021
    New Form of CAR T Cells May Target Genetic Alteration Common to All Cancers
    Immunotherapy

    New Form of CAR T Cells May Target Genetic Alteration Common to All Cancers

    Scientists created a new cancer immunotherapy approach that uses a new type of CAR T cells to stimulate an immune response against cells that are missing one gene copy. They reported their findings in Proceedings of the National Academy of Sciences.

    July 28, 2021
    What Is CRISPR?
    Research

    What Is CRISPR?

    Clustered regularly interspaced short palindromic repeats (CRISPR) is a commonly seen term for readers of science news and literature across a variety of industries. But reading the word often doesn’t automatically translate to understanding it and its implications. Here’s what oncology nurses need to know about CRISPR.

    July 26, 2021
    Biden-Harris Administration’s Drug Policy Priorities Support Prevention, Treatment, and Recovery
    Patient advocacy

    Biden-Harris Administration’s Drug Policy Priorities Support Prevention, Treatment, and Recovery

    Prescription overdoses and addiction rates have dramatically increased in the United States since 2012, with more than 70,000 deaths attributed to the abuse of fentanyl, opioids, cocaine, and methamphetamine in 2019, a 35% increase since 2015. Addressing drug misuse is a top priority for the Biden-Harris administration, as well as researching systematic inequities in the country’s approach to criminal justice and prevention, treatment, and recovery.

    July 21, 2021
    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Next page
    • Last page Last »
    Trending Topics
    • Treatments
    • Research
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    • Cancer research
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2022 Oncology Nursing Society
     
    Back to Top ▲